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Summary.-The secretion of CEA into the blood of athymic mice was studied with
4 sublines of human colonic adenocarcinoma cell lines, HT 29 and SLu. Growth
curves based on tumour volume (caliper measurements) or tumour mass (weight)
correlated with a concomitant increase of serum CEA during the logarithmic growth
phase, but showed a marked dissociation when the growth rate slowed down. In the
logarithmic growth phase doubling times between 2 and 6 days were calculated
and about 6-7 doubling times passed until the shift in the growth rate was observed,
independently of the sublines transplanted. Constant increases of CEA between 0-03
and 0-45 Fg/l serum per mm3 increase of tumour volume, depending on the sublines,
were recorded during thelogarithmicgrowthphase. Sublinesreleasing high amounts
of CEA in vitro (cell culture) retained this characteristic in vivo. Correlation between
tumour volume and tumour mass or serum CEA showed correlation coefficients of
0-8200-977 during the logarithmic growth phase.
THE OBSERVATION by Pantelouris (1968)
that nu/nu mice lack morphological and
functional thymus glands opened up the
possibility for the use of these animals in
xenograft experiments. Rygaard &
Povlsen (1969) were the first to grow
heterotransplanted tumours in nude mice.
Since then numerous experiments with
xenografted human malignant tumours
into thymus-deficient mice have been pub-
lished from which it is evident that human
tumour transplants in athymic mice can
retain certain characteristics of the orig-
inal tumour cell line (Pesce et al., 1977;
Helson et al., 1975; Dipersio et al., 1980;
Papsidero et al., 1981). In this context it is
of special interest to seek human tumours
capable of producing carcinoembryonic
antigen (CEA) when grafted into nude
mice.
CEA is a tumour-associated glyco-
protein discovered by Gold & Freedman
(1965) which now has gained considerable
interest as a tumour -marker in the
management of patients with various
tumours. There is general agreement that
the amount of circulating CEA increases
with increasing tumour mass and tumour
extension (Lo Gerfo & Herter, 1975;
Holyoke et at., 1975). However, there are
also cases with metastatic tumour growth
but scarcely any circulating CEA. More-
over, unexplained fluctuations of the
serum CEA concentrations are frequently
detected in patients which can lead to
severe misinterpretation of the clinical
course of disease (Rittgers et al., 1978;
Staab et at., 1979).
Several investigators (Sordat et al.,
1974; Miwa et at., 1976; Carrel et al., 1976;
Stragand et al., 1980) have reported
detection ofCEA in the blood ofnude mice
after transplantation of colonic carcin-
omas into animals. While Miwa et al.H. J. STAAB AND F. A. ANDERER
(1976) reported a positive correlation,
Stragand et al. (1980) did not find any
correlation between tumour size and
circulating serum CEA levels in the
xenografted mice.
The present study was designed to
investigate extensively the kinetics of
CEA release of 2 human tumour cell lines
in the nude mouse system using 4 different
sublines ofhuman CEA-releasing cells, 2 of
which were low in vitro releasers and 2 high
in vitro releasers of CEA. The results
indicated astrict correlation ofCEArelease
during the logarithmic growth phase ofthe
transplanted tumour cells and the size of
the developing tumour.
MATERIALS AND METHODS
Mice.-Inbred STU mice (Committee on
standardized nomenclature for inbred strains
of mice, 1968) were used to derive inbred
nude mice. The nude mice were kept under
pathogen-limited conditions according to
the guide-lines given by the Committee on
care and use of the "nude mouse" (1976).
The animals generally survived 8 months.
Cell linbes.-HT 29 cells (originally estab-
lished byJ.Fogh,SloanKetteringInstitutefor
Cancer Research N.Y.) were obtained from
Dr Warnatz, Erlangen, F.R.G. Two sublines,
HT 29-1 and HT 29-2, secreting different
amounts of CEA/106 cells/day, were cloned
in our laboratory. CEA release in cell cultures
(Falcon flasks with 2 x 106 cells/4 ml growth
medium) was found to be 13-6 f4g/l/106
cells/day (HT 29-1) and 6-2 /Ig/l/106 cells/
day (HT 29-2), respectively.
The SLu cell lines were established in our
laboratory from a liver metastasis of a
patient with an adencarcinoma of the sig-
moid colon. The tumour was first maintained
in nude mice for 10 passages and thereafter
grown in tissue culture. Different sublines
were derived from a fast growing (SLu-1)
and from a slowly growing (SLu-2) tumour,
both releasing significant amounts of CEA.
The Slu-2 cell line is a low releaser with a
CEA output of 0-2 jug/l/106 cells/day and
the SLu-1 cell line a high releaser with a
CEA output of 7 flg/J/106 cells/day into the
growth medium.
Transplantation experiments.-Nude mice
were inoculated s.c. on Day 0 with 106
viable tumour cells to grow palpable tumours
in 100% of the animals within a period of
5-18 days depending on the transplanted
cell line. Sera of 3 mice were pooled and the
average tumour volume and/or tumour mass
was evaluated. In other experiments up to
40 individual animals were followed in their
growth of tumour.
Tumourgrowth.-Tumourgrowth was mon-
itored weekly or twice a week by caliper
measurements ofthe tumours in 3 dimensions.
The tumour volume was calculated by the
formula V=(iT/6)a2b assuming a prolateellip-
soid (a=smallest diameter, b=greatest dia-
meter). In a series of experiments we addi-
tionally obtained the tumour mass by
excising and weighing the prepared tumour
tissues.
Sera.-Mice were bled from the retro-
orbital sinus yielding 200-250 ,ul serum per
animal.
CEA determination.-Serum CEA con-
centrations were determined with the CEA
Roche RIA test kit. The indirect assay was
used throughout the experiments. CEA
concentrations >20,ug/l were measured after
appropriate dilution of the sera. Control
nude mouse serum did not contain measurable
amounts of CEA.
RESULTS
Growth curves
The growth curves of HT 29 and SLu
cells injected s.c. into the flanks of nude
mice characterized by tumour volume and
serum CEA concentration followed Gom-
pertzian growth behaviour (Fig. 1). The
tumours grew locally and metastases were
not observed. All sublines exhibited an
apparent lag phase of tumour growth
followed by a period of 17-36 days of
logarithmic growth depending on the
xenografted tumour cell subline. There-
after, we observed decreasing growth rates
generally followed by a plateau of tumour
growth. The serum CEA concentration,
concomitantly measured, matched exactly
the growth characteristics ofthe cell lines,
thus reflecting accurately the various
phases oftumour growth. In Fig. la, b the
growth characteristics expressed by serum
CEA increase paralleling the development
oftumourvolume are depicted for HT 29-1
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FIG. 1.-Growth curves of HT 29-1 (a), HT 29-2 (b), SLu-2 (c), SLu-I (d) human colonic adeno-
carcinoma cell lines in athymic mice. Growth curves are characterized by concomitant determina-
tion of tumour volume and serum CEA concentration. Volumes are given in mean values derived
from 3 animals; CEA was determined from pooled sera.
and HT 29-2 cells. The volume data are
mean values derived from 3 animals; the
CEA data refer to the pooled sera. In Fig.
lb data at Days 51 and 72 were derived
from 2 animals only. The kinetics of the
increases in serum CEA concentration and
tumour development of mice bearing SLu
tumours are given in Fig. Ic, d.
In the Table the in vivo characteristics
of the CEA-releasing HT 29 and SLu
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TABLE.-In vivo characteristics of CEA-releasing HT 29 and SLu tumours in nude mice.
At Day 0 in each subgroup of mice, 3 animals were injected s.c. with 106 cells into the
flanks
Characteristics
Duration of lag
phase from Day
Duration of log
phase from Day
Doubling time (days)
Number of doubling times in
log phase until shift in
growth rate
HT 29-1 HT-29-2 SLu-I
0-7 0-11
8-25
2
12-30 8-37
3 4
8 5 6
SLu-2
sublines in nude mice are summarized. The
HT 29-1 and the HT 29-2 tumours
exhibited tumour doubling times of 2 and
3 days and the doubling times ofSLu-1 and
SLu-2 tumours were calculated as 4 and 6
days respectively. The lag phase oftumour
growth was considerably longer in animals
with slowly growing tumour sublines
compared to the fast growing ones. With
all 4 sublines a decrease in tumour growth
rate took place after 6-8-5 doubling times.
The CEA concentrations per tumour
volume were significantly greater in
animals bearing HT 29-1 and SLu-l
tumours than in mice with transplanted
HT 29-2 or SLu-2 tumours. During the
logarithmic growth phase we calculated a
CEA concentration of 0 45 ,ug/l serum per
mm3 tumour volume for HT 29-1 and 0-32
for SLu-2 tumours. This means that the
various sublines had to grow to tumours of
different size until measurable amounts of
circulating CEA were found in the blood of
the hosts. Comparing HT 29 or SLu cells in
our experiments on the basis of CEA
release, we found that each of the faster
growing sublines released a greater
amount of CEA, suggesting a direct
correlation of CEA release with tumour
growth rates.
In another experimental series, we
determined the tumour mass after
excision, preparation and weighing of the
tumours together with the levels of the
circulating CEA in mice bearing HT 29-1
or HT 29-2 tumours. The experiments
resulted in tumour growth curves similar
to that obtained after external determina-
tion of the tumour volume by caliper
measurements.
Mass/8volume relationship
HT 29-1 tumour volumes were also
determined by caliper measurements
before tumour excision. In Fig. 2 the
externally determined mean volumes of
the HT 29-1 tumours were plotted against
the corresponding mean weights of the
excised tumours. Each mean value of
tumour volume and mass was obtained
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FIG. 2. Correlation between tumour volume
(external caliper measurements) and
tumour mass (excised tumour weight) in
athymic mice (correlation coefficient 0.953).
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from 3 animals which were killed between
Days 7 and 56. There was a very good
correlation of tumour volumes in the
animals with tumours up to 800 mg. The
regression line was calculated with a
correlation coefficient of 0 953 between
tumour mass and tumour volume. The
mass of HT-29-1 tumours equivalent to
100 mm3 oftumour volume was calculated
as 148 mg.
Mass/CEA and volume/CEA relationship
The relationship between tumour mass
and serum CEAwasestablishedinHT 29-1
and HT 29-2 tumour-bearing mice. In this
series only tumours from animals without
macroscopic evidence of tumour necrosis
were evaluated. The mice were bled before
tumour excision and were the same
animals as those referred to in Fig. 2. The
tumours were excised between Days 7 and
56 and the mean values of the tumour
masses of 3 animals were correlated with
the serum CEA concentration of the
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corresponding pooled sera. The correlation
coefficient between tumour mass and
circulating CEA was found to be 0 977
(n= 14). Individual tumour masses of
animals with HT 29-2 tumours, when
correlated with the individual serum CEA
concentrations, also showed a correlation
with a coefficient of 0 820 (n= 31).
Since there was an excellent relationship
between tumour volume and tumour mass
for the HT 29 sublines (Fig. 2) we
determined a volume/CEA relationship
instead of a tumour mass/CEA relation-
ship to economize on animals. During the
logarithmic growth phase, tumour
volumes ofindividual mice could be deter-
mined 2-3 times together with a corre-
sponding blood sample. The results pre-
sented in Fig. 3a, b also showed a linear
relationship between circulating CEA and
tumour volume. This finding proved
that the release of CEA into the blood of
the individual hosts by SLu-I and SLu-2
sublines increased linearly with increasing
soum CEA [W/|
FIG. 3.-Correlation of tumour volume and serum CEA concentrations in individual SLu-1 (a)
(correlation coefficient 0*839), and individual SLu-2 (b) tumour-bearing athymic mice (correlation
coefficient 0* 847).
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tumour volumes during the logarithmic
growth phase of the tumours. The corre-
lation coefficient of tumour volume to
CEA serum concentration was calculated
to 0-839 for the SLu-I (n== 55) and 0-847
for the SLu-2 subline (n=23). The CEA
blood concentration equivalent to 100
mm3 tumour tissue was calculated to be
3 65 and 30 2 /tg/l for the SLu-2 and the
SLu-l subline respectively.
DISCUSSION
Our studies in nude mice produced
evidence for an intrinsic relationship of in
vivo CEA release and tumour growth of
human colonic carcinoma HT 29 and SLu
sublines releasing different amounts of
CEA into the host circulation. In this
animal model the serum concentration of
the human tumour marker, CEA, proved
to be an excellent growth parameter
directly correlated with tumour size. A
critical examination of the various phases
oftumour growth indicated that this strict
correlation was upheld only in the
logarithmic growth phase. The shift to
slower growth rates was linked to the
dissociation of serum CEA and tumour
volume leading to lower levels of circula-
ting CEA. The critical tumour mass ofs.c.-
growing tumours at which the shift to
slower growth rates occurred was 800-
1200 mg independent of the tumour cell
sublines. These tumours frequently
showed macroscopic necrosis. The length
of logarithmic growth phases of s.c.
growing tumours depended highly on the
doubling times ofthe cell line and required
6-8 5 doubling times to reach the shift in
the growth rate. The CEA output of HT
29 and SLu sublines in vivo reflected the
CEA release of the cells in vitro. The
sublines releasing high amounts ofCEA in
vitro alsoretained this characteristic invivo,
though we have to expect CEA catabolism
in the mouse (Thomas & Hems, 1975). The
findings of Miwa et al. (1976) concerning
the linear relation of tumour mass and
circulating CEA have been confirmed and
widely extended in our investigations. The
conflicting results published by Stragand
et al. (1980), who did not find a correlation
between tumour size and serum CEA
levels with the LoVo adenocarcinoma cell
line transplanted into nude mice, may
come in part from evaluating animals with
tumours at different growth phases. In a
recent publication by Lewis & Keep (1981)
no clear correlation between serum CEA
levels and tumour size was reported. They
used xenografted tumour tissue which
developed central necrosis as a consistent
feature when grown in nude mice.
Necrosis as an interfering event for the
linear relation of a serum tumour marker
and tumour size has been described for
AFP-secreting human teratomas in
immunosuppressed mice (Raghavan et al.,
1980). Our observations that fluctuations
of the serum CEA concentration occurred
only after the shift from logarithmic to
slower growth rates, associated with the
frequent appearance ofmacroscopic necro-
sis, might also reflect a direct interference
of tumour necrosis with CEA release.
Experiments to characterize a possible
influence of tumour necrosis on CEA
release are in progress.
The authors \ivsh to thiaink Als S. Glock for
excellent technical assistance.
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